Current and Future Applications of Fluorescence-Guided Surgery in Head and Neck Cancer
- PMID: 36243502
- DOI: 10.1016/j.soc.2022.07.001
Current and Future Applications of Fluorescence-Guided Surgery in Head and Neck Cancer
Abstract
Despite improvements in medical management of head and neck cancers, positive surgical margin rates have remained relatively unchanged in the past 30 years, emphasizing a need for improved intraoperative imaging and tumor visualization. This review provides a detailed summary on preoperative anatomic imaging techniques, nonspecific fluorescence imaging modalities, the recent emergence of tumor-targeting fluorophores for intraoperative imaging, and the future of fluorescence-guided surgery in head and neck cancer.
Keywords: Fluorescence-guided surgery; Near-infrared imaging; Nonspecific fluorophores; Positive surgical margins; Tumor-targeting fluorophores.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have nothing to disclose.
Similar articles
-
Intraoperative Fluorescence-Guided Surgery in Head and Neck Squamous Cell Carcinoma.Laryngoscope. 2021 Mar;131(3):529-534. doi: 10.1002/lary.28822. Epub 2020 Jul 3. Laryngoscope. 2021. PMID: 33593036 Review.
-
Infrared Fluorescence-guided Surgery for Tumor and Metastatic Lymph Node Detection in Head and Neck Cancer.Radiol Imaging Cancer. 2024 Jul;6(4):e230178. doi: 10.1148/rycan.230178. Radiol Imaging Cancer. 2024. PMID: 38940689 Free PMC article. Review.
-
The Sentinel Margin: Intraoperative Ex Vivo Specimen Mapping Using Relative Fluorescence Intensity.Clin Cancer Res. 2019 Aug 1;25(15):4656-4662. doi: 10.1158/1078-0432.CCR-19-0319. Epub 2019 May 29. Clin Cancer Res. 2019. PMID: 31142505 Free PMC article. Clinical Trial.
-
Image-guided surgery in head and neck cancer: current practice and future directions of optical imaging.Head Neck. 2012 Jan;34(1):120-6. doi: 10.1002/hed.21625. Epub 2011 Jan 31. Head Neck. 2012. PMID: 21284051 Review.
-
Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study.Theranostics. 2020 Mar 4;10(9):3994-4005. doi: 10.7150/thno.43227. eCollection 2020. Theranostics. 2020. PMID: 32226534 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous